114 related articles for article (PubMed ID: 36264776)
21. Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer.
van der Doelen MJ; Isaacsson Velho P; Slootbeek PHJ; Pamidimarri Naga S; Bormann M; van Helvert S; Kroeze LI; van Oort IM; Gerritsen WR; Antonarakis ES; Mehra N
Eur J Cancer; 2020 Sep; 136():16-24. PubMed ID: 32634759
[TBL] [Abstract][Full Text] [Related]
22. Analysis of mutations in DNA damage repair pathway gene in Chinese patients with hepatocellular carcinoma.
Li J; Li N; Azhar MS; Liu L; Wang L; Zhang Q; Sheng L; Wang J; Feng S; Qiu Q; Xiao Y
Sci Rep; 2022 Jul; 12(1):12330. PubMed ID: 35853969
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value and functional bioinformatic analysis of spindle- and kinetochore-associated protein 1 in stage IIA esophageal squamous cell carcinoma.
Hu D; Zhang M; Peng Z
J Cancer Res Ther; 2020 Sep; 16(5):1157-1164. PubMed ID: 33004764
[TBL] [Abstract][Full Text] [Related]
24. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
[TBL] [Abstract][Full Text] [Related]
25. RECQL4 regulates DNA damage response and redox homeostasis in esophageal cancer.
Lyu G; Su P; Hao X; Chen S; Ren S; Zhao Z; Gong Y; Liu Q; Shao C
Cancer Biol Med; 2021 Feb; 18(1):120-138. PubMed ID: 33628589
[TBL] [Abstract][Full Text] [Related]
26. A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma.
Li XC; Wang MY; Yang M; Dai HJ; Zhang BF; Wang W; Chu XL; Wang X; Zheng H; Niu RF; Zhang W; Chen KX
Ann Oncol; 2018 Apr; 29(4):938-944. PubMed ID: 29351612
[TBL] [Abstract][Full Text] [Related]
27. Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma.
Cui Y; Chen H; Xi R; Cui H; Zhao Y; Xu E; Yan T; Lu X; Huang F; Kong P; Li Y; Zhu X; Wang J; Zhu W; Wang J; Ma Y; Zhou Y; Guo S; Zhang L; Liu Y; Wang B; Xi Y; Sun R; Yu X; Zhai Y; Wang F; Yang J; Yang B; Cheng C; Liu J; Song B; Li H; Wang Y; Zhang Y; Cheng X; Zhan Q; Li Y; Liu Z
Cell Res; 2020 Oct; 30(10):902-913. PubMed ID: 32398863
[TBL] [Abstract][Full Text] [Related]
28. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
29. Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.
Yan T; Cui H; Zhou Y; Yang B; Kong P; Zhang Y; Liu Y; Wang B; Cheng Y; Li J; Guo S; Xu E; Liu H; Cheng C; Zhang L; Chen L; Zhuang X; Qian Y; Yang J; Ma Y; Li H; Wang F; Liu J; Liu X; Su D; Wang Y; Sun R; Guo S; Li Y; Cheng X; Liu Z; Zhan Q; Cui Y
Nat Commun; 2019 Apr; 10(1):1670. PubMed ID: 30975989
[TBL] [Abstract][Full Text] [Related]
30. Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma.
Park S; Joung JG; Min YW; Nam JY; Ryu D; Oh D; Park WY; Lee SH; Choi Y; Ahn JS; Ahn MJ; Park K; Sun JM
J Immunother Cancer; 2019 May; 7(1):128. PubMed ID: 31097034
[TBL] [Abstract][Full Text] [Related]
31. Profile of esophageal squamous cell carcinoma mutations in Brazilian patients.
Munari FF; Dos Santos W; Evangelista AF; Carvalho AC; Pastrez PA; Bugatti D; Wohnrath DR; Scapulatempo-Neto C; Guimarães DP; Longatto-Filho A; Reis RM
Sci Rep; 2021 Oct; 11(1):20596. PubMed ID: 34663841
[TBL] [Abstract][Full Text] [Related]
32. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K
Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701
[TBL] [Abstract][Full Text] [Related]
33. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
Jin D; Yuan L; Li F; Wang S; Mao Y
BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
[TBL] [Abstract][Full Text] [Related]
34. BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese.
Ko JM; Ning L; Zhao XK; Chai AWY; Lei LC; Choi SSA; Tao L; Law S; Kwong A; Lee NP; Chan KT; Lo A; Song X; Chen PN; Chang YL; Wang LD; Lung ML
Int J Cancer; 2020 Feb; 146(4):1042-1051. PubMed ID: 31396961
[TBL] [Abstract][Full Text] [Related]
35. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
Yang JW; Choi YL
Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
[TBL] [Abstract][Full Text] [Related]
36. Mutations in DNA damage response pathways as a potential biomarker for immune checkpoint blockade efficacy: evidence from a seven-cancer immunotherapy cohort.
Zhang W; Zhang L; Jiang H; Li Y; Wang S; Wang Q
Aging (Albany NY); 2021 Nov; 13(21):24136-24154. PubMed ID: 34747718
[TBL] [Abstract][Full Text] [Related]
37. Genomic analyses reveal SCN7A is associated with the prognosis of esophageal squamous cell carcinoma.
Yuan P; Rao W; Lin Z; Liu S; Lin X; Wu C; Lin X; Hu Z; Ye W
Esophagus; 2022 Apr; 19(2):303-315. PubMed ID: 34993672
[TBL] [Abstract][Full Text] [Related]
38. UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma.
Wang X; Liu Y; Leng X; Cao K; Sun W; Zhu J; Ma J
Pathol Oncol Res; 2021; 27():632531. PubMed ID: 34257599
[No Abstract] [Full Text] [Related]
39. Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC.
Zhang H; Zhang D; Liu J; Shi Y; Liu X; Chen M; Zhong W; Zhao J; Xu Y; Wang M
Thorac Cancer; 2023 Nov; 14(32):3191-3201. PubMed ID: 37704455
[TBL] [Abstract][Full Text] [Related]
40. Alterations in DNA Damage Repair Genes in Primary Liver Cancer.
Lin J; Shi J; Guo H; Yang X; Jiang Y; Long J; Bai Y; Wang D; Yang X; Wan X; Zhang L; Pan J; Hu K; Guan M; Huo L; Sang X; Wang K; Zhao H
Clin Cancer Res; 2019 Aug; 25(15):4701-4711. PubMed ID: 31068370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
